_____________________________________________________________________________________ Paxman
Scalp Cooling
Supportive care in the late 1990s was largely non-existent and launching a product into that environment came with significant challenges. Medical professionals’ core focus was firmly on curing cancer, and hair loss was not widely regarded as a clinical priority, despite being deeply distressing for patients. Side effect management was still in its infancy, as the industry had only just started managing nausea and sickness. In Richard’ s view, his father’ s product came to market too early, and that timing created real barriers to entry from the outset.
“ Coming from a background in beer cooling and refrigeration engineering, without medical device experience or clinical data to support the product, made for an uphill challenge. However, early venture capital investment supported the company and enabled it to fund clinical trials, work with the NHS, and conduct product development through pilots and iteration. Moving forward, the key for me is that we
manufacturing-today. com 111